VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P28
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -27.15% |
| Q3 2025 | 26.67% |
| Q2 2025 | -85.67% |
| Q1 2025 | 1.26% |
| Q4 2024 | 5.20% |
| Q3 2024 | 0.61% |
| Q2 2024 | -51.00% |
| Q1 2024 | -51.20% |
| Q4 2023 | 22.79% |
| Q3 2023 | 21.56% |
| Q2 2023 | -5.60% |
| Q1 2023 | 24.87% |
| Q4 2022 | 39.23% |
| Q3 2022 | -1.37% |
| Q2 2022 | -3.56% |
| Q1 2022 | -29.42% |
| Q4 2021 | -4.74% |
| Q3 2021 | -81.88% |
| Q2 2021 | -19.13% |
| Q1 2021 | -3.26% |
| Q4 2020 | -667.99% |
| Q3 2020 | 132.24% |
| Q2 2020 | -8.82% |
| Q1 2020 | 39.73% |
| Q4 2019 | -3.45% |
| Q3 2019 | 13.12% |
| Q2 2019 | -33.69% |
| Q1 2019 | 8.85% |
| Q4 2018 | 3.82% |
| Q3 2018 | -28.12% |
| Q2 2018 | -21.86% |
| Q1 2018 | -6.43% |
| Q4 2017 | -30.22% |
| Q3 2017 | 12.03% |
| Q2 2017 | -40.12% |
| Q1 2017 | 27.39% |
| Q4 2016 | 5.00% |
| Q3 2016 | -31.97% |
| Q2 2016 | -25.67% |
| Q1 2016 | -13.40% |